Description: NYBC Ventures is a $50M venture fund. Our focus is to improve patient’s lives & drive blood & cell therapy discovery, collaboration & research. Learn more.
Working with NYBC Ventures goes beyond capital. We provide access to world-renowned researchers and their labs, cell manufacturing capacity, and source materials.
Early-stage companies pursuing advancements in blood-related and cellular therapeutics & technologies
Companies that would benefit from a partnership with Lindsley F. Kimball Research Institute (LFKRI) researchers and cell manufacturing and sourcing capabilities